16.200
−6,90%
2026-10-14
Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +5.8% | +22.9% | 3 / 3 | +5.7% | +1.60 pp | +0.00 pp | +10.1% | 3.08 | 5.70 | 511 | +5,7% | 11,7 | +5,8% | 5.70 | 8.01 | −28,9% |
| Pts | 0 | 0 | 12 | 0 | 8 | 8 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 16.200 (close price on 2026-10-14)EPS (TTM): 2.843
Financial charts
1.Revenue & growth
VND bn511Q2/26
1.Revenue & growth
VND bn511Q2/26
2.Profit & growth
VND bn11,7Q2/26
3.Profit mix (Penman)
VND bn53,9Q2/26
4.Margins & cost structure
%6.3%Q2/26
5.Returns & cash cycle
% · days7.9%Q2/26
6.Earnings quality & cash
VND bn-92,1Q2/26
7.Asset structure
VND bn3.237Q2/26
8.Funding & debt health
VND bn · times3.237Q2/26
9.Revenue backlog
VND bn1.093Q2/26
10.Valuation
times · %5,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %778Q2/26
Adjusted EPS growth, latest quarter
5.8%
Average adjusted EPS growth, 3 quarters
22.9%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26